- Home
- ETON vs SLND Comparison
ETON vs SLND Comparison
Compare ETON & SLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- SLND
- Stock Information
- Founded
- ETON 2017
- SLND 1900
- Country
- ETON United States
- SLND United States
- Employees
- ETON N/A
- SLND N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- SLND Military/Government/Technical
- Sector
- ETON Health Care
- SLND Industrials
- Exchange
- ETON Nasdaq
- SLND Nasdaq
- Market Cap
- ETON 199.5M
- SLND 160.7M
- IPO Year
- ETON 2018
- SLND N/A
- Fundamental
- Price
- ETON $10.02
- SLND $3.02
- Analyst Decision
- ETON Strong Buy
- SLND Buy
- Analyst Count
- ETON 3
- SLND 2
- Target Price
- ETON $12.00
- SLND $5.50
- AVG Volume (30 Days)
- ETON 212.9K
- SLND 104.7K
- Earning Date
- ETON 11-12-2024
- SLND 11-12-2024
- Dividend Yield
- ETON N/A
- SLND N/A
- EPS Growth
- ETON N/A
- SLND N/A
- EPS
- ETON N/A
- SLND N/A
- Revenue
- ETON $34,677,000.00
- SLND $1,029,117,999.00
- Revenue This Year
- ETON $19.61
- SLND $0.91
- Revenue Next Year
- ETON $82.71
- SLND $5.38
- P/E Ratio
- ETON N/A
- SLND N/A
- Revenue Growth
- ETON 5.64
- SLND N/A
- 52 Week Low
- ETON $3.03
- SLND $1.85
- 52 Week High
- ETON $11.11
- SLND $6.16
- Technical
- Relative Strength Index (RSI)
- ETON 67.30
- SLND 47.23
- Support Level
- ETON $8.76
- SLND $1.85
- Resistance Level
- ETON $11.11
- SLND $3.23
- Average True Range (ATR)
- ETON 0.66
- SLND 0.40
- MACD
- ETON 0.10
- SLND 0.01
- Stochastic Oscillator
- ETON 62.02
- SLND 67.63
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About SLND Southland Holdings Inc.
Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures.